期刊
BREAST CANCER RESEARCH AND TREATMENT
卷 137, 期 2, 页码 329-336出版社
SPRINGER
DOI: 10.1007/s10549-012-2351-7
关键词
Transcription factors; Feedback loop; Cell signaling; Drug resistance; DNA damage response
类别
资金
- NIH [R01-CA102289]
- Ocala Royal Dames for Cancer Research
- Florida Department of Health
Owing to numerous pro-survival target genes, aberrant activation of the NF-kappa B transcription factor is associated with a drug-resistant phenotype and aggressive breast tumor behavior. Transglutaminase 2 (TG2), a ubiquitously expressed protein cross-linking enzyme, activates NF-kappa B through a non-conventional mechanism that disables the I kappa B alpha inhibitor. Our group has recently documented that the TG2 gene (termed TGM2) is a direct transcriptional target of NF-kappa B. These developments uncover a novel self-reinforcing molecular feedback loop where TG2 activates NF-kappa B and, in turn, NF-kappa B directly upregulates the transcription of TGM2. This manuscript reviews the literature that supports the existence of the TG2/NF-kappa B signaling loop, the nature of the signal transduction that activates this loop, and the phenotypic consequences stemming from the aberrant activation of this novel signaling mechanism in breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据